Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Sunitinib

2

XII.a Left or biventricular dysfunction/failure

3
Last update : 22/10/2014
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Sorafenib
2

Publications

Cardiotoxicity Monitoring in Patients Treated with Tyrosine Kinase Inhibitors.
The oncologist 2019 Jul;24;e600-e602 2019 Jul
Lung toxicity in a patient treated with sunitinib.
The European respiratory journal 2012 Nov;40;1300-3 2012 Nov
Incidence and risk of congestive heart failure in patients with renal and nonrenal cell carcinoma treated with sunitinib.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Sep 01;29;3450-6 2011 Sep 01
Targeted therapies: Risk of heart failure with sunitinib.
Nature reviews. Clinical oncology 2011 Aug 16;8;569 2011 Aug 16
Management of cardiac adverse events occurring with sunitinib treatment.
Anticancer research 2009 May;29;1627-9 2009 May
Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate.
Annals of oncology : official journal of the European Society for Medical Oncology 2008 Sep;19;1613-8 2008 Sep
Acute cardiac failure after sunitinib.
Annals of oncology : official journal of the European Society for Medical Oncology 2008 Mar;19;597-9 2008 Mar
Heart failure associated with sunitinib malate: a multitargeted receptor tyrosine kinase inhibitor.
Cancer 2008 Jun;112;2500-8 2008 Jun
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib.
Lancet (London, England) 2007 Dec 15;370;2011-9 2007 Dec 15

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies